Pathstone Holdings’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,871
Closed -$243K 2266
2024
Q4
$243K Buy
16,871
+571
+4% +$8.84K ﹤0.01% 2069
2024
Q3
$258K Buy
16,300
+530
+3% +$8.36K ﹤0.01% 2048
2024
Q2
$242K Buy
+15,770
New +$239K ﹤0.01% 2053
2024
Q1
Sell
-15,143
Closed -$222K 2302
2023
Q4
$222K Buy
+15,143
New +$211K ﹤0.01% 2016

Other funds holding BMEZ

Pathstone Holdings's BMEZ Position: Q1 2025 in Review

Pathstone Holdings sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 16,871 shares — an estimated $243K sold.

Pathstone Holdings first reported a position in BMEZ in Q4 2023 and held it in 4 quarters. The position peaked at $258K in Q3 2024. 98 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • Pathstone Holdings reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 16,871 BlackRock Health Sciences Trust II shares in Q1 2025, an estimated $243K.
  • Pathstone Holdings first reported a position in BlackRock Health Sciences Trust II in Q4 2023 and held it in 4 quarters.
  • Pathstone Holdings's BlackRock Health Sciences Trust II position peaked at $258K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.